Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 10/2015

01-10-2015 | Original

Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial

Authors: Frédérique Schortgen, Anaïs Charles-Nelson, Lila Bouadma, Geoffray Bizouard, Laurent Brochard, Sandrine Katsahian

Published in: Intensive Care Medicine | Issue 10/2015

Login to get access

Abstract

Purpose

We previously showed that external cooling decreases day 14 mortality in febrile septic shock. Because cooling may participate in heart rate control, we studied the respective impact of heart rate and temperature lowering on mortality.

Methods

Post hoc analysis of the Sepsiscool randomized controlled trial database (NCT00527007). Cooling was applied to maintain normothermia (36.5–37 °C) during 48 h. We assessed the time spent below different thresholds of temperature and heart rate on day 14 mortality. The best threshold was selected by AUC-ROC and tested as a potential mediator of mortality reduction. Mediation analysis was adjusted for severity and treatments influencing temperature and heart rate evolution. Sensitivity analysis was done using only patients with appropriate antimicrobial therapy.

Results

A total of 197/200 patients with adequate heart rate and temperature monitoring were analyzed. The best threshold differentiating survivors and nonsurvivors was 38.4 °C for temperature and 95 b/min for heart rate. During the 48 h of intervention, cooling significantly increased the time spent with a temperature below 38.4 °C, p = 0.001, and with a heart rate below 95 b/min, p < 0.01. The longer was the time spent with a temperature below 38.4 °C, the lower was the mortality [adjOR 0.17 (0.06–0.49), p = 0.001]. The time spent with a heart rate below 95 b/min was similar in survivors and nonsurvivors [adjOR 0.68 (0.27–1.72), p = 0.42]. Mediation analysis showed that the time spent with a temperature below 38.4 °C was a significant mediator of mortality.

Conclusion

The time spent with a temperature below 38.4 °C was independently associated with patient’s outcome and explained 73 % of the effect of the randomization on the day 14 mortality. Heart rate lowering was not a mediator of mortality.
Literature
1.
Barie PS, Hydo LJ, Eachempati SR (2004) Causes and consequences of fever complicating critical surgical illness. Surg Infect 5:145–159CrossRef
2.
Kiekkas P, Velissaris D, Karanikolas M, Aretha D, Samios A, Skartsani C, Baltopoulos GI, Filos KS (2009) Peak body temperature predicts mortality in critically ill patients without cerebral damage. Heart Lung 39:208–216CrossRefPubMed
3.
Selladurai S, Eastwood GM, Bailey M, Bellomo R (2011) Paracetamol therapy for septic critically ill patients: a retrospective observational study. Crit Care Resusc 13:181–186PubMed
4.
Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF (2012) Determinants of temperature abnormalities and influence on outcome of critical illness. Crit Care Med 40:145–151CrossRefPubMed
5.
Kushimoto S, Gando S, Saitoh D, Mayumi T, Ogura H, Fujishima S, Araki T, Ikeda H, Kotani J, Miki Y, Shiraishi SI, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N (2013) The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis. Crit Care 17:R271PubMedCentralCrossRefPubMed
6.
Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group, Lee BH, Inui D, Suh GY, Kim JY, Kwon JY, Park J, Tada K, Tanaka K, Ietsugu K, Uehara K, Dote K, Tajimi K, Morita K, Matsuo K, Hoshino K, Hosokawa K, Lee KH, Lee KM, Takatori M, Nishimura M, Sanui M, Ito M, Egi M, Honda N, Okayama N, Shime N, Tsuruta R, Nogami S, Yoon SH, Fujitani S, Koh SO, Takeda S, Saito S, Hong SJ, Yamamoto T, Yokoyama T, Yamaguchi T, Nishiyama T, Igarashi T, Kakihana Y, Koh Y (2012) Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care 16:R33CrossRef
7.
Young PJ, Saxena M, Beasley R, Bellomo R, Bailey M, Pilcher D, Finfer S, Harrison D, Myburgh J, Rowan K (2012) Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med 38:437–444CrossRef
8.
Manthous CA, Hall JB, Olson D, Singh M, Chatila W, Pohlman A, Kushner R, Schmidt GA, Wood LD (1995) Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 151:10–14CrossRefPubMed
9.
Bernard GR, Wheeler AP, Russell JA, Schein R, Summer WR, Steinberg KP, Fulkerson WJ, Wright PE, Christman BW, Dupont WD, Higgins SB, Swindell BB (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336:912–918CrossRefPubMed
10.
Gozzoli V, Treggiari MM, Kleger GR, Roux-Lombard P, Fathi M, Pichard C, Romand JA (2004) Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 30:401–407CrossRefPubMed
11.
Taccone FS, Saxena M, Schortgen F (2014) What’s new with fever control in the ICU. Intensive Care Med 40:1147–1150CrossRefPubMed
12.
Nakamura K (2011) Central circuitries for body temperature regulation and fever. Am J Physiol Regul Integr Comp Physiol 301:R1207–R1228CrossRefPubMed
13.
Russell JA (2012) Control of fever in septic shock: should we care or intervene? Am J Respir Crit Care Med 185:1040–1041CrossRefPubMed
14.
Dunser MW, Hasibeder WR (2009) Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 24:293–316CrossRefPubMed
15.
Nalivaiko E (2006) Tachycardia during fever: is it neural or humoral? Am J Physiol Regul Integr Comp Physiol 290:R1750CrossRefPubMed
16.
Takayama K, Yuhki K, Ono K, Fujino T, Hara A, Yamada T, Kuriyama S, Karibe H, Okada Y, Takahata O, Taniguchi T, Iijima T, Iwasaki H, Narumiya S, Ushikubi F (2005) Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. Nat Med 11:562–566CrossRefPubMed
17.
18.
Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med 37:1344–1351CrossRefPubMed
19.
Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D’Egidio A, D’Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683–1691CrossRefPubMed
20.
Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L (2012) Fever control using external cooling in septic shock: a randomized controlled trial. Am J Respir Crit Care Med 185:1088–1095CrossRefPubMed
21.
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710CrossRefPubMed
22.
Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR (2005) SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31:1345–1355PubMedCentralCrossRefPubMed
23.
Poukkanen M, Wilkman E, Vaara ST, Pettila V, Kaukonen KM, Korhonen AM, Uusaro A, Hovilehto S, Inkinen O, Laru-Sompa R, Hautamaki R, Kuitunen A, Karlsson S (2013) Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study. Crit Care 17:R295PubMedCentralCrossRefPubMed
24.
Amato MB, Meade MO, Slutsky AS, Brochard L, Costa EL, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, Richard JC, Carvalho CR, Brower RG (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372:747–755CrossRefPubMed
25.
Imai K, Keele L, Tingley D (2010) A general approach to causal mediation analysis. Psychol Methods 15:309–334CrossRefPubMed
26.
Tingley D, Yamamoto T, Hirose K, Keele L, Imai K (2014) Mediation: R package for causal mediation analysis. J Stat Softw 59:1–38
27.
Poblete B, Romand JA, Pichard C, Konig P, Suter PM (1997) Metabolic effects of i.v. propacetamol, metamizol or external cooling in critically ill febrile sedated patients. Br J Anaesth 78:123–127CrossRefPubMed
28.
Mohr NM, Fuller BM, Skrupky LP, Moy H, Alunday R, Micek ST, Fagley RE (2011) Clinical and demographic factors associated with antipyretic use in gram-negative severe sepsis and septic shock. Ann Pharmacother 45:1207–1216PubMedCentralCrossRefPubMed
29.
Niven D, Laupland K, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF (2013) Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators survey. Crit Care 17:R289PubMedCentralCrossRefPubMed
30.
O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, Masur H (2008) Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36:1330–1349CrossRefPubMed
31.
Schortgen F (2012) Fever in sepsis. Minerva Anestesiol 78:1254–1264PubMed
32.
Seguin P, Roquilly A, Mimoz O, Maguet PL, Asehnoune K, Biederman S, Carise E, Malledant Y (2012) Risk factors and outcomes for prolonged versus brief fever: a prospective cohort study. Crit Care 16:R150PubMedCentralCrossRefPubMed
33.
Parker MM, Shelhamer JH, Natanson C, Alling DW, Parrillo JE (1987) Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923–929CrossRefPubMed
34.
Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, Whittemore AD (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88:477–482PubMed
35.
Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riche F, Laisne MJ, Payen D, Mebazaa A (2008) Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock. J Trauma 64:1188–1195CrossRefPubMed
36.
Leibovici L, Gafter-Gvili A, Paul M, Almanasreh N, Tacconelli E, Andreassen S, Nielsen AD, Frank U, Cauda R, Group TS (2007) Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM 100:629–634CrossRefPubMed
37.
38.
Groeneveld AB, Nauta JJ, Thijs LG (1988) Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med 14:141–147CrossRefPubMed
39.
Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H, Lefevre LM, Bollaert PE, Boulain T, Luis D, Cariou A, Girardie P, Chelha R, Megarbane B, Delahaye A, Chalumeau-Lemoine L, Legriel S, Beuret P, Brivet F, Bruel C, Camou F, Chatellier D, Chillet P, Clair B, Constantin JM, Duguet A, Galliot R, Bayle F, Hyvernat H, Ouchenir K, Plantefeve G, Quenot JP, Richecoeur J, Schwebel C, Sirodot M, Esposito-Farese M, Le Tulzo Y, Wolff M (2013) Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA 310:2174–2183CrossRefPubMed
40.
Saxena M, Young P, Pilcher D, Bailey M, Harrison D, Bellomo R, Finfer S, Beasley R, Hyam J, Menon D, Rowan K, Myburgh J (2015) Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection. Intensive Care Med 41:823–832PubMedCentralCrossRefPubMed
41.
Staer-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Draegni T, Nakstad ER, Eritsland J, Andersen GO (2014) Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest. Crit Care Med 42:2401–2408CrossRefPubMed
Metadata
Title
Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial
Authors
Frédérique Schortgen
Anaïs Charles-Nelson
Lila Bouadma
Geoffray Bizouard
Laurent Brochard
Sandrine Katsahian
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 10/2015
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-015-3987-7

Other articles of this Issue 10/2015

Intensive Care Medicine 10/2015 Go to the issue

Editorial

Measuring acute kidney injury around the world: are we using the right thermometer (and adequately)?

Original

A novel pump-driven veno-venous gas exchange system during extracorporeal CO2-removal

Editorial

From weaning theory to practice: implementation of a quality improvement program in ICU

Original

Regional variation in critical care provision and outcome after high-risk surgery

From the Inside

Sounding board: is mandatory recovery of organs for transplantation acceptable?

Editorial

Should cost considerations be included in medical decisions? Yes